From: Clinical features of inflammatory bowel disease unclassified: a case-control study
 | IBDU (20) | UC- reclassified (9) | p-value | CD- reclassified (8) | p-value |
---|---|---|---|---|---|
albuminemia (g/L), mean ± sd | 35.0 ± 6.2 | 30.4 ± 6.5 | 0.049 | 33.0 ± 6.9 | 0.386 |
mucopurulent bloody stool, n (%) | 12(60.0%) | 8(88.9%) | 0.201 | 4(50.0%) | 0.691 |
hemorrhage, n (%) | 3(15.0%) | 4(44.4%) | 0.158 | 5(62.5%) | 0.022 |
perforation, n (%) | 1(5.0%) | 2(22.2%) | 0.220 | 2(25.0%) | 0.188 |
perianal disease, n (%) | 4(20.0%) | 2(22.2%) | 1.000 | 5(62.5%) | 0.068 |
fistula, n (%) | 4(20.0%) | 1(11.1%) | 0.654 | 4(50.0%) | 0.172 |
obstruction, n (%) | 6(30.0%) | 1(11.1%) | 0.382 | 5(62.5%) | 0.200 |
rectal involvement, n (%) | 7(35.0%) | 5(55.6%) | 0.422 | 3(37.5%) | 1.000 |
stricture, n (%) | 13(65.0%) | 7(77.8%) | 0.675 | 7(87.5%) | 0.371 |
segmental lesion, n (%) | 15(75.0%) | 6(66.7%) | 0.483 | 5(62.5%) | 0.651 |
longitudinal ulcer, n (%) | 8(40.0%) | 2(22.2%) | 0.431 | 5(62.5%) | 0.410 |
crypt abscess, n (%) | 11(55.0%) | 5(55.6%) | 1.000 | 5(62.5%) | 1.000 |
granuloma, n (%) | 1(5.0%) | 0(0.0%) | 1.000 | 1(12.5%) | 0.497 |
Surgery, n (%) | 6(30.0%) | 3(33.3%) | 1.000 | 6(75.0%) | 0.044 |
Corticosteroid, n (%) | 19(95.0%) | 9(100.0%) | 1.000 | 8(100.0%) | 1.000 |
IM, n (%) | 9(45.0%) | 7(77.8%) | 0.130 | 7(87.5%) | 0.088 |
IFX, n (%) | 4(20.0%) | 1(11.1%) | 1.000 | 4(50.0%) | 0.172 |